Argenta Discovery

Argenta Discovery is a drug research and development company focused on the respiratory system. Argenta is developing a range of new therapies to treat serious conditions such as chronic obstructive pulmonary disease (COPD), severe steroid-insensitive asthma, allergic asthma, and cystic fibrosis (CF), with the aim of improving symptom relief and addressing the underlying inflammatory processes. Argenta intends to advance its programs through Phase IIa proof-of-concept clinical trials before seeking partnerships.